<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01559467</url>
  </required_header>
  <id_info>
    <org_study_id>NL37574.068.11 / METC 11-2-077</org_study_id>
    <nct_id>NCT01559467</nct_id>
  </id_info>
  <brief_title>The Supplementary Role of Non-invasive Imaging to Routine Clinical Practice in Suspected Non-ST-elevation Myocardial Infarction</brief_title>
  <acronym>CARMENTA</acronym>
  <official_title>The Supplementary Role of Cardiovascular Magnetic Resonance Imaging and Computed Tomography Angiography to Routine Clinical Practice in Suspected Non-ST Elevation Myocardial Infarction - A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dutch Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Approximately half of patients with acute chest pain, a very common reason for emergency
      department visits worldwide, have a cardiac cause. Two-thirds of patients with a cardiac
      cause are eventually diagnosed with a so-called non-ST-elevation myocardial infarction. The
      diagnosis of non-ST-elevation myocardial infarction is based on a combination of symptoms,
      electrocardiographic changes, and increased serum cardiac specific biomarkers (high-sensitive
      troponin T). Although being very sensitive of myocardial injury, increased high-sensitive
      troponin T levels are not specific for myocardial infarction. Invasive coronary angiography
      is still the reference standard for coronary imaging in suspected non-ST-elevation myocardial
      infarction. This study investigates whether non-invasive imaging early in the diagnostic
      process (computed tomography angiography (CTA) or cardiovascular magnetic resonance imaging
      (CMR)) can prevent unnecessary invasive coronary angiography. For this, patients will be
      randomly assigned to either one of three strategies: 1) routine clinical care and computed
      tomography angiography early in the diagnostic process, 2) routine clinical care and
      cardiovascular magnetic resonance imaging early in the diagnostic process, or 3) routine
      clinical care without non-invasive imaging early in the diagnostic process.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">June 19, 2017</completion_date>
  <primary_completion_date type="Actual">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total number of patients with at least one invasive coronary angiography during initial admission</measure>
    <time_frame>During initial hospital admission, an expected average of 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Thirty-day clinical outcome (a composite of major adverse cardiac events [MACE] and major procedure related complications)</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>One-year clinical outcome (a composite of major adverse cardiac events [MACE] and major procedure related complications)</measure>
    <time_frame>One-year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>One-year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-effectiveness</measure>
    <time_frame>After study completion, expected after 3 years</time_frame>
    <description>The economic evaluation will be a cost-effectiveness analysis, with quality-adjusted life years (QALYs) as outcome measure. Effects will be calculated in terms of QALYs. To investigate the cost-effectiveness of the three strategies, incremental cost-effectiveness ratios (ICERs) will be calculated. Cost-effectiveness acceptability curves (CEACs) are derived in order to show the probability of each strategy being the optimal choice, for a range of possible maximum values a decision maker is willing to pay for a QALY.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiogoniometry</measure>
    <time_frame>After study completion, expected after 3 years</time_frame>
    <description>A retrospective analysis will be performed to investigate whether CGM performed on the cardiac emergency department can differentiate between a coronary and non-coronary etiology in suspected NSTEMI</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Chest Pain</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Coronary Artery Disease</condition>
  <condition>Myocardial Ischemia</condition>
  <arm_group>
    <arm_group_label>Routine clinical care plus early CMR</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine clinical care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine clinical care plus early CTA</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiovascular Magnetic Resonance Imaging</intervention_name>
    <description>Routine clinical care plus cardiovascular magnetic resonance imaging early in the diagnostic process</description>
    <arm_group_label>Routine clinical care plus early CMR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Computed Tomography Angiography</intervention_name>
    <description>Routine clinical care plus computed tomography angiography early in the diagnostic process</description>
    <arm_group_label>Routine clinical care plus early CTA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Prolonged symptoms suspected of cardiac origin (angina pectoris or angina equivalent),
             and presentation on the cardiac emergency department &lt;24 hours after symptom onset

               -  Increased levels of high-sensitive Troponin-T (&gt;14ng/L)

               -  Age &gt;18 years and &lt;85 years

               -  Willing and capable to give written informed consent

               -  Written informed consent

        Exclusion Criteria:

          -  Ongoing severe ischemia requiring immediate invasive coronary angiography

          -  Shock (mean arterial pressure &lt; 60 mmHg) or severe heart failure (Killip Class ≥ III)

          -  ST-elevation myocardial infarction (ST-elevation in 2 contiguous leads: ≥0.2mV in men
             or ≥0.15 mV in women in leads V2-V3 and/or ≥0.1 mV in other leads or new left bundle
             branch block)

          -  Chest pain highly suggestive of non-cardiac origin:

               -  Acute aortic dissection

               -  Acute pulmonary embolism (high risk patient defined as Wells score &gt;6)

               -  Musculoskeletal or gastro-intestinal pain

               -  Other (pneumothorax, pneumonia, rib fracture, etc.)

          -  Previously known coronary artery disease, defined as:

               -  Any non-invasive diagnostic imaging test positive for coronary artery disease

               -  Coronary stenosis &gt;50% on any previous invasive coronary angiography or computed
                  tomography angiography

               -  Documented previous myocardial infarction

               -  Documented previous coronary artery revascularization

               -  Known cardiomyopathy

          -  Pregnancy

          -  Life threatening arrhythmia on the cardiac emergency department or prior to
             presentation

          -  Tachycardia (≥100/bpm)

          -  Atrial fibrillation

          -  Angina pectoris secondary to anemia (&lt;5.6 mmol/L), untreated hyperthyroidism, aortic
             valve stenosis (aortic valve area ≤ 1.5 cm2), or severe hypertension (&gt;200/110 mmHg)

          -  Life expectancy &lt;1 year (malignancy, etc.)

          -  Contraindications to cardiovascular magnetic resonance imaging: metallic implant
             (vascular clip, neuro-stimulator, cochlear implant), pacemaker or implantable cardiac
             defibrillator, claustrophobia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harry J Crijns, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joachim Wildberger, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6202 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 1997 Dec 4;337(23):1648-53.</citation>
    <PMID>9385123</PMID>
  </reference>
  <reference>
    <citation>Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009 Aug 27;361(9):858-67. doi: 10.1056/NEJMoa0900428.</citation>
    <PMID>19710484</PMID>
  </reference>
  <reference>
    <citation>Kim HW, Farzaneh-Far A, Kim RJ. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol. 2009 Dec 29;55(1):1-16. doi: 10.1016/j.jacc.2009.06.059. Review.</citation>
    <PMID>20117357</PMID>
  </reference>
  <reference>
    <citation>Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr; 2011 WRITING GROUP MEMBERS; ACCF/AHA TASK FORCE MEMBERS. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 May 10;123(18):e426-579. doi: 10.1161/CIR.0b013e318212bb8b. Epub 2011 Mar 28. Erratum in: Circulation. 2011 Jun 7;123(22):e627.</citation>
    <PMID>21444888</PMID>
  </reference>
  <reference>
    <citation>Hoenig MR, Aroney CN, Scott IA. Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD004815. doi: 10.1002/14651858.CD004815.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD004815.</citation>
    <PMID>20238333</PMID>
  </reference>
  <reference>
    <citation>Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation. 2001 Jun 12;103(23):2780-3.</citation>
    <PMID>11401931</PMID>
  </reference>
  <reference>
    <citation>Kwong RY, Schussheim AE, Rekhraj S, Aletras AH, Geller N, Davis J, Christian TF, Balaban RS, Arai AE. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation. 2003 Feb 4;107(4):531-7.</citation>
    <PMID>12566362</PMID>
  </reference>
  <reference>
    <citation>Leurent G, Langella B, Fougerou C, Lentz PA, Larralde A, Bedossa M, Boulmier D, Le Breton H. Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome and unobstructed coronary arteries. Arch Cardiovasc Dis. 2011 Mar;104(3):161-70. doi: 10.1016/j.acvd.2011.01.005. Epub 2011 Apr 2.</citation>
    <PMID>21497305</PMID>
  </reference>
  <reference>
    <citation>Meijboom WB, Mollet NR, Van Mieghem CA, Weustink AC, Pugliese F, van Pelt N, Cademartiri F, Vourvouri E, de Jaegere P, Krestin GP, de Feyter PJ. 64-Slice CT coronary angiography in patients with non-ST elevation acute coronary syndrome. Heart. 2007 Nov;93(11):1386-92. Epub 2007 Mar 7.</citation>
    <PMID>17344332</PMID>
  </reference>
  <reference>
    <citation>Vanhoenacker PK, Decramer I, Bladt O, Sarno G, Bevernage C, Wijns W. Detection of non-ST-elevation myocardial infarction and unstable angina in the acute setting: meta-analysis of diagnostic performance of multi-detector computed tomographic angiography. BMC Cardiovasc Disord. 2007 Dec 19;7:39. Review.</citation>
    <PMID>18093295</PMID>
  </reference>
  <reference>
    <citation>Hoffmann U, Bamberg F, Chae CU, Nichols JH, Rogers IS, Seneviratne SK, Truong QA, Cury RC, Abbara S, Shapiro MD, Moloo J, Butler J, Ferencik M, Lee H, Jang IK, Parry BA, Brown DF, Udelson JE, Achenbach S, Brady TJ, Nagurney JT. Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. J Am Coll Cardiol. 2009 May 5;53(18):1642-50. doi: 10.1016/j.jacc.2009.01.052.</citation>
    <PMID>19406338</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2012</study_first_submitted>
  <study_first_submitted_qc>March 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2012</study_first_posted>
  <last_update_submitted>July 3, 2017</last_update_submitted>
  <last_update_submitted_qc>July 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myocardial infarction</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Coronary Angiography</keyword>
  <keyword>Tomography, X-Ray Computed</keyword>
  <keyword>Mortality</keyword>
  <keyword>Complications</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Cost-Benefit Analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
    <mesh_term>Non-ST Elevated Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

